Galmed Pharma's Registration Statement Becomes Effective
Ticker: GLMD · Form: EFFECT · Filed: 2026-04-02T00:15:10-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, pharmaceuticals
TL;DR
Galmed Pharma's SEC filing is now effective, clearing the way for potential stock offerings.
AI Summary
Galmed Pharmaceuticals Ltd. filed an EFFECT form on April 2, 2026, indicating the effectiveness of a registration statement. The filing relates to Act 33 and has the file number 333-289703. The company's fiscal year ends on December 31st.
Why It Matters
This filing signifies that Galmed Pharmaceuticals can now proceed with the sale of securities, potentially raising capital for its operations or expansion.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming the effectiveness of a registration statement, not indicating new financial performance or market-moving events.
Key Numbers
- 2026-04-01 — Effectiveness Date (The date the registration statement became effective.)
- 333-289703 — File Number (Identifies the specific registration filing.)
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Filer
- 0001595353 (company) — CIK
- 333-289703 (dollar_amount) — File Number
- 2026-04-02 (date) — Acceptance Date
- 2026-04-01 (date) — Effectiveness Date
FAQ
What is the purpose of an EFFECT filing?
An EFFECT filing, or Notice of Effectiveness, is filed with the SEC to indicate that a previously filed registration statement has become effective, allowing the sale of securities.
When did Galmed Pharmaceuticals' registration statement become effective?
The registration statement for Galmed Pharmaceuticals Ltd. became effective on April 1, 2026.
What is the CIK number for Galmed Pharmaceuticals Ltd.?
The CIK number for Galmed Pharmaceuticals Ltd. is 0001595353.
What is the file number associated with this filing?
The file number associated with this filing is 333-289703.
What is the business address listed for Galmed Pharmaceuticals Ltd.?
The business address listed is C/O MEITAR LAW OFFICES, 16 ABBA HILLEL SILVER RD., RAMAT GAN L3 5250608.
From the Filing
EDGAR Filing Documents for 9999999995-26-001038 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001038 Accepted 2026-04-02 00:15:10 Documents 1 Effectiveness Date 2026-04-01 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 610 Complete submission text file 9999999995-26-001038.txt 1817 Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448 Galmed Pharmaceuticals Ltd. (Filer) CIK : 0001595353 (see all company filings) EIN. : 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-289703 | Film No.: 26830444 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)